Assessment Report di Comirnaty di Pfizer/BioNTech, vedi pag. 102 e segg. punto 3.3. Uncertainties and limitations about favourable effects e punto 3.5. Uncertainties and limitations about unfavourable effects
![](https://www.renate-holzeisen.eu/wp-content/uploads/2022/03/Screenshot-2022-03-09-at-17.01.05.png)
Assessment Report di Comirnaty di Pfizer/BioNTech, vedi pag. 102 e segg. punto 3.3. Uncertainties and limitations about favourable effects e punto 3.5. Uncertainties and limitations about unfavourable effects